EGFR and neoplasm: In this study we developed a novel, modular platform utilizing human IgG1 for generation of multivalent single-chain derivatives of the apoptosis-inducing TNF homology domain of TRAIL in combination with targeting of tumour-associated antigens, here demonstrated for EGFR.